Replies to post #69061 on Savvy Trades and Investments

[zenvesting]

IPATF: Now that's a company that's going to need more financing soon and this statement at the end of their 2.20/2020 PR seems to have tempered any enthusiasm for the upside:

There is no assurance that the Company will be successful in the development of a vaccine and/or therapeutic against the new coronavirus. In particular, the development of a vaccine and/or therapeutic requires significant capital, which will require additional financing by the Company, successful clinical trials and extensive regulatory approvals.

https://finance.yahoo.com/news/immunoprecise-launches-coronavirus-vaccine-therapeutic-193900358.html

I also know a few of their long-term investors, who are skeptical that their relatively new CEO, Jennifer Bath, hasn't put much of any skin in the game yet....even at these depressed prices.